Detalles de la búsqueda
1.
Availability of genome-matched therapy based on clinical practice.
Int J Clin Oncol
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38668785
2.
[Overview of Clinical Application of Whole Genome Analysis for Cancer].
Gan To Kagaku Ryoho
; 51(1): 7-13, 2024 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-38247084
3.
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.
Cancer Sci
; 114(12): 4632-4642, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858313
4.
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
Cancer Sci
; 113(5): 1808-1820, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35201661
5.
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
BMC Cancer
; 22(1): 36, 2022 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34983437
6.
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).
Breast Cancer Res Treat
; 190(3): 425-434, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34554370
7.
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 180(2): 331-341, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020432
8.
Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer.
Radiology
; 286(1): 49-57, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28737968
9.
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.
BMC Cancer
; 18(1): 982, 2018 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30326862
10.
Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: a retrospective study.
BMC Cancer
; 16: 404, 2016 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27389013
11.
Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.
Surg Today
; 46(7): 821-6, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467559
12.
Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer.
Breast Cancer Res Treat
; 148(1): 197-209, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25270122
13.
Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling.
Discov Oncol
; 13(1): 109, 2022 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36260237
14.
Druggable gene alterations in Japanese patients with rare malignancy.
Neoplasia
; 33: 100834, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36088851
15.
Assessment of a cancer genomic profile test for patients with metastatic breast cancer.
Sci Rep
; 12(1): 4813, 2022 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315838
16.
[Management of anthracycline and taxane therapy-induced symptoms for the patients with breast cancer].
Nihon Rinsho
; 73 Suppl 2: 548-52, 2015 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-25831820
17.
[A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
Gan To Kagaku Ryoho
; 36(10): 1733-6, 2009 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-19838037
18.
Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review.
Case Rep Oncol
; 10(2): 605-612, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28868019
19.
The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
PLoS One
; 12(9): e0184322, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28898275
20.
A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy.
Case Rep Oncol
; 10(2): 620-626, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28868021